A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 20,895 shares of BSX stock, worth $1.97 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
20,895
Previous 5,585 274.13%
Holding current value
$1.97 Million
Previous $498,000 323.09%
% of portfolio
0.38%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 10, 2025

BUY
$89.38 - $106.18 $1.37 Million - $1.63 Million
15,310 Added 274.13%
20,895 $2.11 Million
Q4 2024

Jan 14, 2025

BUY
$83.62 - $91.5 $150,432 - $164,608
1,799 Added 47.52%
5,585 $498,000
Q3 2024

Oct 11, 2024

BUY
$72.96 - $84.0 $67,633 - $77,868
927 Added 32.42%
3,786 $317,000
Q2 2024

Jul 05, 2024

BUY
$67.33 - $77.71 $192,496 - $222,172
2,859 New
2,859 $220,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $135B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Thurston, Springer, Miller, Herd & Titak, Inc. Portfolio

Follow Thurston, Springer, Miller, Herd & Titak, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thurston, Springer, Miller, Herd & Titak, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thurston, Springer, Miller, Herd & Titak, Inc. with notifications on news.